Literature DB >> 23158087

Technique, outcomes, and evolving role of extirpative laparoscopic and robotic surgery for renal cell carcinoma.

Youssef S Tanagho1, R Sherburne Figenshau, Sam B Bhayani.   

Abstract

This article provides an overview of extirpative laparoscopic and robotic procedures used in the management of renal cell carcinoma, including laparoscopic radical nephrectomy, laparoscopic partial nephrectomy, and robotic-assisted partial nephrectomy. The clinical indications and principles of surgical technique for each of these procedures are discussed. The oncologic, renal functional, and perioperative outcomes of these procedures are also assessed and compared, as are complication rates.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23158087     DOI: 10.1016/j.soc.2012.08.002

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

1.  'Trifecta' outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study.

Authors:  Junya Furukawa; Hiroomi Kanayama; Haruhito Azuma; Keiji Inoue; Yasuyuki Kobayashi; Akira Kashiwagi; Takehiko Segawa; Yoshihito Takahashi; Shigeo Horie; Osamu Ogawa; Atsushi Takenaka; Ryoichi Shiroki; Kazunari Tanabe; Masato Fujisawa
Journal:  Int J Clin Oncol       Date:  2019-11-01       Impact factor: 3.402

2.  Early Single-Center Experience with Robotic Partial Nephrectomy Using the da Vinci Xi: Comparative Assessment with Conventional Open Partial Nephrectomy.

Authors:  Daisuke Motoyama; Ryota Aki; Yuto Matsushita; Keita Tamura; Toshiki Ito; Takayuki Sugiyama; Atsushi Otsuka; Hideaki Miyake
Journal:  Curr Urol       Date:  2019-09-10

3.  Analysis of surgical and histopathological results of robot-assisted partial nephrectomy with use of three or four robotic arms: an early series results.

Authors:  Lucas Schulze; Victor Teixeira Dubeux; José C A Milfont; Gustavo Peçanha; Pedro Ferrer; Andre Guilherme Cavalcanti
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 1.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.